Pages that link to "Q42808862"
Jump to navigation
Jump to search
The following pages link to Emphasizing the burden of proof: The American College of Cardiology 2008 Expert Panel Comments on the ENHANCE Trial (Q42808862):
Displaying 7 items.
- Overview of guidelines for the management of dyslipidemia: EU perspectives (Q28069411) (← links)
- Leveraging human genetics to guide drug target discovery (Q30245007) (← links)
- Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010. (Q34400871) (← links)
- Inactivating mutations in NPC1L1 and protection from coronary heart disease (Q35105445) (← links)
- Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis (Q38420505) (← links)
- Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs (Q38546242) (← links)
- Human genetic insights into lipoproteins and risk of cardiometabolic disease (Q38774074) (← links)